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ABSTRACT
Objective. The aim of this study was to 
analyze whether structured data collec-
tion of patients with community-acquired 
pneumonia (CAP) in the Emergency De-
partment (ED) improves compliance with 
clinical guidelines regarding inpatient and 
outpatient treatment and prescription of 
antibiotics at discharge. 
Material and methods. We performed a 
quasi experimental, multicenter, pre/post-
intervention study. The intervention con-
sisted of basic training for the participat-
ing physicians and the incorporation of a 
data collection sheet in the clinical history 
chart, including the information neces-
sary for adequate decision making re-
garding patient admission and treatment, 
in the case of discharge. We analyzed the 
adequacy of the final destination of pa-
tients classified as Fine I-II and antibiotic 
treatment in patients receiving outpatient 
treatment, with each participating physi-
cian including 8 consecutive patients (4 
pre-intervention and 4 post-intervention).
Results. A total of 738 patients were in-
cluded: 378 pre-intervention and 360 
post-intervention. In the pre-intervention 
group, Fine V was more frequent and pa-
tients were older, had more ischemic heart 
disease, active neoplasms and fewer risk 
factors for atypical pneumonia. Of the 
patients with Fine I-II, 23.7% were in-
adequately admitted and 19.6% of those 
discharged received treatment not rec-
ommended by guidelines. No differences 
were observed in the target variables be-
tween the two groups. 
Conclusion. The adequacy of the decision 
to admit patients with Fine I-II CAP and 
outpatient antibiotic treatment can be im-
proved in the ED. Structured data collec-
tion does not improve patient outcome. 
Key words: community-acquired pneu-
monia, emergency department, antibiotic 
treatment, adequacy of admission 
INTRODUCTION
The incidence of community-acquired 
pneumonia (CAP) is around 2-5 cas-
es/1,000 inhabitants per year, which may 
rise up to 15-35 during periods of viral 
epidemia. (1) The economic impact of 
CAP is high, (2) with an important dif-
ference in costs based on whether the 
patient is treated in the hospital or as an 
outpatient. (3) Therefore, two key aspects 
for the management of less severe CAP 
are to assess whether the patient really re-
quires hospital admission and to correctly 
choose antibiotic treatment for patients 
who are discharged. Both decisions are 
often made by staff working in emergency 
departments (ED). With regard to the de-
cision of hospital admission, prognostic 
scales, such as the FINE (4) or CURB65 
(5), have long been used. According to 
current clinical guidelines, the combina-
tion of these scales, with relevant clinical 
aspects, defines the critieria of hospital 
admission. (6-9) On the other hand, these 
same guidelines indicate the antibiotics 
of choice for patients who are discharged 
with the aim of avoiding therapeutic fail-
ure and the appearance of bacterial resist-
ance. (10)
Although some studies have reported the 
inadequacy of hospital admission and 
antibiotic treatment in CAP (11), and 
others have shown that compliance with 
protocols and clinical guidelines improves 
patient outcome, (12) no study has deter-
mined the effect of other interventions to 
minimize these dysfunctions. Thus, the 
present study evaluated the grade of com-
pliance of ED physicians with the guide-
lines regarding hospital admission and 
outpatient treatment of patients with CAP, 
as well as the effects of a training inter-
vention and the incorporation of a struc-
tured data collection sheet in improving 
this compliance. Our hypothesis was that 
providing emergency physicians with a 
notebook containing a structured data 
collection sheet that allocates the patient 
into a specific category and suggests anti-
biotic selection, would in turn improve the 
ratio of patients being managed according 
to guidelines. 
MATERIALS AND METHODS 
Study design 
We performed a quasi experimental, mul-
ticenter pre/post intervention study in 
49 EDs corresponding to 8 autonomous 
communities and including both tertiary 
university and county hospitals. The pre-
sent study is a sub-study of the INSPIRA 
study (investigation of the adequacy of 
the management of patients with CAP 
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and acute descompensation of chronic 
obstructive pulmonary disease (COPD) 
in Spanish EDs) which was designed prior 
to its initiation. In the pre-intervention 
phase, a variable number of investigators 
was contacted from each center (1 – 4) 
to retrospectively collect data for the last 
4 patients with CAP treated by these in-
vestigators. Th e intervention consisted 
of providing a data collection notebook 
which contains all the epidemiological, 
clinical and laboratoty variables necessary 
to retrieve all the clinical data necessary 
for adequate decision making. Among 
other data, this notebook also included 
all the items necessary to classify patients 
according to the Fine scale, as well as the 
antibiotics recommended at discharge 
from the ED. Th e participating physi-
cians were the same in both phases of the 
study and they received specifi c training 
on completing the data collection sheet 
and were advised that the assessment of 
the adequacy of decision making regard-
ing admission and antibiotic treatment 
prescribed would follow the prevailing 
guidelines. Th is training was of no longer 
than 60 minutes. It did not include specifi c 
training as to the content of the guidelines 
in order to isolate the intervention and 
considering the objective of analyzing the 
adequacy of the management of a highly 
frequent disease with widely dissemi-
nated and updated guidelines. During the 
post-intervention phase, 4 consecutive 
episodes of CAP treated by each of the 
participating physicians were collected. 
During the preintervention phase, data 
collection was done at the discretion of 
the emergency physicians, and during the 
post-intervention phase, data were entred 
into the notebook so all data necessary for 
FINE calculation was collected. Later, an 
external CRO (clinical research organiza-
tion) transferred all data into a database, 
as well as the missing values, by accessing 
medical reports. Aft er completing the da-
tabase, researchers checked around 3% of 
data randomly, in order to ascertain the 
consistency and accuracy of the database.
Th e inclusion criteria were: over 18 years 
of age and having signed informed con-
sent. Th e protocol was approved by the 
Ethical Committee of each participating 
center. CAP was defi ned according to the 
criteria of the Infectious Diseases Society 
of America. (13)
Th e decision as to hospital admission from 
the ED was made by the attending ED 
physician. In doubtful cases, diff erent spe-
cialists (respiratory physicians, internal 
medicine physicians...) were consulted for 
a consensus decision regarding discharge. 
Study period
From January 2010 to April 2012.
Variables
Th e independent variables collected includ-
ed epidemiologic (age, sex, place of resi-
dence, vaccinations, risk factors for atypical 
pneumonia), clinical (past history and his-
tory of the current episode in the ED), radi-
ological, analytical and variables related to 
treatment. Suspecting CAP atypical bacte-
ria, blood serology was conducted, includ-
ing Legionella pneumophila urinary anti-
gen detection (Binax Now L. Pneumophila 
Urinary Antigen Test; Trinity Biotech, Bray, 
Ireland). With these data the patients were 
classifed according to the Fine criteria. To 
evaluate the target variables of the study, 
only patients classifi ed as Fine I or II were 
taken into account, given that these stages 
are of greatest concern when undertreating 
patients using the optional protocol. Two 
target variables were considered (depend-
ent). Th e fi rst was the percentage of inad-
equate admissions involving patients with 
CAP Fine I or II who were admitted to hos-
pital, despite the absence of comorbidities, 
pleural eff usion, respiratory insuffi  ciency 
or added social problems. Th e second vari-
able was the percentage of patients with 
CAP discharged directly from the ED with 
inadequate antibiotic treatment, according 
to the criteria of the guidelines of the Span-
ish Society of Medical Emergencies and 
Emergency Medicine (SEMES) prevailing 
at the time of the study. Th ese guidelines 
recommend combinations of beta-lactam-
ics and a macrolide or monotherapy with a 
fl uoroquinolone. (9)  
STATISTICAL ANALYSIS 
Th e data were collected with an electronic 
notebook for data collection which had 
been specially designed for the study. Th e 
database included ranges and rules for in-
ternal coherence to guarantee quality of 
the data. Th e categorical variables are ex-
pressed as absolute and relative frequencies 
while continuous variables are expressed 
as mean, standard deviation, median, and 
minimum and maximum values. To com-
pare the pre- and post-intervention groups, 
parametric tests (Student’s t) or nonpara-
metric tests (Mann-Whitney U) were used 
for the quantitative variables according to 
the characteristics of distribution of the 
study variables. For the qualitative vari-
ables, the Chi-square test was used or the 
Fisher’s exact test if the values were less 
than 5. Statistical analyses were performed 
using the statistical package SAS version 
9.1.3. 
RESULTS 
A total of 738 patients with CAP were in-
cluded in the study, 378 in the pre-interven-
tion phase and 360 in the post-intervention 
phase (2 and 20 patients, respectively were 
excluded from each period because of a 
lack of fundamental data in the data collec-
tion notebook). Table 1 shows the distribu-
tion of the patients in each group. Th e pre-
intervention group was signifi cantly older, 
had a greater percentage of patients with 
active neoplasm, ischemic heart disease or 
classifi ed as Fine V, and the patients with 
the risk of having atypical pneumonia was 
lower compared with the post-intervention 
group.
Table 2 shows the classifi cation of the pa-
Figure 1. Distribution of inadequate 
hospital admissions based on the Fine scale. 
Figure 2. Distribution of the prescription of 
inadequate treatment at patient discharge 
in patients with community acquired 
neumonia (CAP) Fine I or II. Patients were 
deemed to receive adequate treatment with 
the prescription of an antibiotic schedule 
strictly adjusted to the recommendations of 
the prevailing guidelines. Inadequate 
treatment was considered as that with 
insuffi  cient coverage, and non-recommend-
ed drug combinations were considered as 
those with an unnecessary antibiotic 
combination (fl uoroquinolone + amoxicil-
lin-clavulanic acid or fl uoroquinolone + 
cefuroxime). 
       SIGNA VITAE    |    43
tients according to the Fine scale. A total of 
299 patients were classified as Fine I and II, 
with no statistically significant differences 
between the pre- and post-intervention 
phases. With regard to this classification, 
it is of note that the percentage of patients 
with CAP Fine V was greater in the pre-
intervention group.
Among the 299 patients with Fine I and II, 
71 (23.7%) were inappropriately admitted 
to hospital, 32 (23.9%) in the pre-inter-
vention and 39 (29.1%) in the post-inter-
vention groups. These differences were not 
statistically significant for either the global 
or individualized analysis of the Fine I and 
II patients (figure 1). The percentage of 
patients treated on an outpatient basis re-
duced with the increase in the Fine scale, 
although statistically significant differences 
were only observed in patients with CAP 
Fine IV who were more frequently treated 
as outpatients in the post-intervention 
group (table 2).
No differences were observed in empiric 
antibiotic treatment administered to pa-
tients treated as outpatients or among all 
patients treated (table 3) or in isolated less 
severe patients, according to the Fine clas-
sification (figure 2). Of patients classified as 
Fine I and II, 14 (20%) in the pre-interven-







Age (years) (mean (SD)) 65,7 (19.2) 62.5 (19.7) 0.025*
Sex (male) (n (%)) 229 (60.5%) 205 (56.9%) 0.104
Active smoker (n (%)) 195 (51.5%) 197 (54.7%) 0.410
Lives in a residence (n (%)) 45 (11.9%) 22 (5.8%) 0.062
Anti-pneumoccocal vaccination (n (%)) 36 (9.5%) 60 (15.9%) 0.207
Anti-influenza vaccination (n (%)) 118 (31.2%) 167 (44.2%) 0.135
Risk of atypical pneumonia (n (%)) 12 (3.1%) 41 (10.9%) 0.001*
PAST HISTORY
Diabetes 97(25.6%) 71(19.7%) 0.054
Chronic obstructive pulmonary disease 82(21.6%) 82(22.8%) 0.723
Ischemic heart disease 51(13.4%) 32(8.9%) 0.047*
Cardiac insufficiency 45(11.9%) 37(10.3%) 0.482
Cerebral vascular accident 39(10.3%) 29(7.7%) 0.288
Renal insufficiency 27(7.1%) 32(8.5%) 0.382
Active neoplasm 40(10.5%) 18(4.8%) 0.004*
Asthma 21(5.5%) 27(7.1%) 0.284
Diagnosis of pneumonia in the previous 12 months (n (%)) 33(8.7) 31(8.6) 0.109
Hospitalization for pneumonia in the previous 12 months (n (%)) 20(5.2) 20(5.6) 0.586
CURRENT EPISODE OF PNEUMONIA
Vital signs
Respiratory rate (rpm) (mean (SD)) 22.3 (6.1) 21.6 (6.2) 0.218
Diastolic blood pressure (Mg.) (mean (SD)) 128.1 (23.3) 129.4 (24.3) 0.539
Temperature (ºC) (mean (SD)) 37.4 (1.1) 37.4 (1.1) 0.968
Heart rate (bpm) (mean (SD)) 97.3 (18.3) 96.1 (18.5) 0.946
Basal oxygen saturation (%)(mean (SD)) 90.8 (6.7) 91,5 (6.0) 0.224
Patients with GCS 15 points (n (%)) 367(97.1%) 351(97.5%) 0.587
Chest X-ray findings
Single infiltrate 296(78.3%) 292(81.1%) 0.260
Multiple infiltrates 77(20.4%) 62(17.2%) 0.287
Pleural  effusion 41(10.9) 32(8.9%) 0.079
Analytical data
Leucocytes (cells/mm3) (mean (SD)) 13037 (6067) 12966 (6054) 0.917
C-reactive protein (mean (SD)) 15.3 (18.5) 16.5 (19.5) 0.924
Sodium (mmol/l) (mean (SD)) 137.0 (5.1) 137.1 (4.1) 0.840
bpm, beats per minute; GCS, Glascow coma score; n, number; rpm, respirations per minute; SD, standard deviation. * significant dif-
ference
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tion group and 18 (19.4%) in the post-in-
tervention group received inadequate treat-
ment, being treated with monotherapy not 
recommended in the guidelines. Likewise, 
6 patients (8.6%) in the  pre-intervention 
and 10 (10.8%) in the post-intervention 
group were treated with drug combinations 
not recommended in the guidelines. 
Table 2. Distribution of patients with community acquired neumonia (CAP) based on the Fine scale and the percentage of patients treated 
on an outpatient basis. 
Pre-intervention group N= 378
n (%)
Post-intervention group N =360
n (%)
p
Fine I 81 (21.6) 105 (29.6) 0.181
Fine II 53 (14.4) 60 (17.5) 0.355
Fine III 70 (18.7) 56 (15.8) 0.320
Fine IV 127 (33.9) 109 (30.7) 0.096
Fine V 46 (12.3) 30 (7.9) 0.029*
Patients treated as outpatients 
Fine I 53 (65.4) 70 (66.6) 0.330
Fine II 17 (32.0) 23 (38.3) 0.338
Fine III 4 (5.7) 9 (16.0) 0.257
Fine IV 2 (1.57) 5 (4.5) 0.018*
Fine V 1 (2.17) 0 (0) 1.00
* significant difference 
Table 3. Distribution of antibiotics administered to outpatients (including all the Fine groups).
Pre-intervention group N= 77
n (%)





11 (14.2) 16 (14.9) 0.907
Cefuroxime (monotherapy) 1 (1.2) 2 (1.8) 0.171
Clarithromycin (monotherapy) 2 (2.5) 0 (0) 0.170
Levofloxacin 500 mg/day 26 (33.7) 42 (39.2) 0.058
Levofloxacin 1000 mg/day 4 (5.1) 4 (3.7) 0.152
Ciprofloxacin 0 (0) 1 (0.9) 1.00
Moxifloxacin 23 (29.8) 24 (22.4) 0.052
Beta-lactamics + macrolide 4 (5.1) 8 (7.4) 0.138
Unnecessary combinations 6 (7.7) 10 (9.3) 0.124
DISCUSSION
The present study demonstrates that the 
risk of patients with milder forms of CAP 
continues to be overestimated, with almost 
one out of every four patients with CAP 
Fine I-II (23.7 %) being admitted to hos-
pital even when not fulfilling strict crite-
ria for hospitalization, thereby increasing 
both the risk and economic costs. This is 
not surprising, but even when all medical 
participants were provided with a note-
book containing guidelines, adherence was 
not 100% by all profesionals.
Since the publication of the Fine scale (4) 
or CURB65, (5) which includes the use of 
risk scales, many studies have shown that 
patient risk is overestimated in the deci-
sion making related to admission from the 
ED. (14) On the other hand, CAP is a very 
prevalent disease and the guidelines are 
regularly updated and widely available. If 
this is so, why does decision making in the 
ED not follow the recommendations of the 
guidelines? Many factors may influence 
decision making. Among others, the spe-
cial working conditions in the ED, the high 
heterogeneity in their organization, greater 
or lesser access to the clinical history of the 
patient and the non-homogeneous train-
ing of  ED professionals. (15-17) On the 
other hand, the availability of observation 
or short-stay areas may contribute to im-
proving the adequacy of decision making, 
and these are not present in all EDs. (18,19) 
The aim of the present study cannot be an-
swered by studies involving an interven-
tion which follows the recommendations 
of the guidelines, (20,21) that is, to deter-
mine whether the problem lies in data col-
lection in the ED, which is an essential step 
in decision making. To answer this ques-
tion we took into account the wide diffu-
sion of clinical practice guidelines and the 
knowledge that these recommendations 
should be part of correct medical practice 
of ED professionals. For this reason, in our 
study, no recommendation was provided, 
but rather the professional was simply 
given the data collection notebook which 
should be considered, in some way, use-
ful as a guide to collect all the information 
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for adequate decision making. It should 
be considered, that in the pre-intervention 
phase of the present study the physician 
calculated the Fine score retrospectively 
from the clinical history, that is, after the 
decision regarding in- or outpatient treat-
ment had been made. We cannot be sure 
if this classification had been done or not 
when the attending physician decided 
whether to admit the patient. In contrast, 
in the post-intervention phase, there was 
no doubt as to whether all the patients had 
been assessed using the risk scale. None-
theless, there continues to be a trend in 
overestimating the risk and unnecessar-
ily admitting patients. Our study presents 
different results from similar studies, al-
though the methdology used in them is 
different. Hinojosa et al (22) described a 
percentage of inadequate admissions of 
only 6 % in their study, also designed in 
two phases. Nonetheless, they included pa-
tients with CAP Fine III in a single center 
and thus, the patients were recruited by the 
same ED physicians working homogene-
ously and a modification in their behavior 
cannot be ruled out by the fact of being 
observed (Hawthorne effect) having influ-
enced the final result. (23) In the study by 
Julian-Jiménez et al (12) the approach was 
different, with the intervention involving 
the application of clinical practice guide-
lines for the treatment of CAP. Improve-
ments were obtained in the mortality and 
the remaining indicators of outcome and 
management. It is of note that in this latter 
study the authors used biomarkers in addi-
tion to the Fine scale. 
On the other hand, outpatient treatment, 
which was mainly based on the antibiotic 
prescribed, was not recommended by the 
guidelines in almost one out of every five 
patients (19.6%), and this did not improve 
during the study which promoted the col-
lection of all clinical data necessary for 
adequate decision making. With regard to 
antibiotic treatment, the reasons for not 
following the guidelines remain unknown. 
This is even more surprising in Spain 
where more antibiotics continue to be pre-
scribed than the European mean, probably 
due to the fear of undertreating an infec-
tious disease, (24) which is one of the main 
diagnoses at discharge in Spanish ED. (25) 
In the present case of CAP, this aspect is of 
note, taking into account that the recom-
mendations are simple. The proportion of 
monotherapy with amoxicillin-clavulanic 
acid is particularly remarkable considering 
the availability of safer and more effective 
oral alternatives than one with a wide spec-
trum for atypical microorganisms. (26,27) 
On the other hand, both the choice of the 
antibiotic and the dose are key to ensure 
treatment efficacy and avoid resistance as 
in the case of oral  levofloxacin, (28) with 
which doses lower than the recommended 
1 g/day during the first 24-72 hours con-
tinue to be used.
Our study has several limitations. Firstly, 
despite being multicentric and performed 
in different autonomous communities and 
different level hospitals, participation was 
voluntary and thus, the sample may have 
been biased. It was not a randomized study 
because we wanted the researches to be 
the same in both phases. If we had rand-
omized, some researches would have had a 
chance to use the case report form (or “the 
data collection sheet”) while others would 
not. We belived that the study design in 
two phases eliminated the bias that the 
selction of researchers could cause.
On the other hand, the definition of inad-
equate hospital admission is always debat-
able considering that aspects such as the 
personal circumstances of the patients or 
their settings may influence the decision to 
admit the patient, overlooking more objec-
tive criteria. Finally, as mentioned above, 
the availability of observation or short-stay 
units which allow reassessment of the pa-
tient and thus, more adequate admission is 
not consistent in all the centers. Nonethe-
less, we believe that the information ob-
tained on the management of CAP of low 
severity (Fine I and II) and the outpatient 
antibiotic treatment prescribed in Spanish 
EDs is significant and orientative in that 
there is an important margin for improve-
ment on the one hand, and on the other, 
the reason for not following the guidelines 
does not seem to be related to structured 
collection of clinical data necessary for 
adequate decision making. The reasons 
underlying the systematically observed de-
viation from the protocols for CAP in the 
ED should be studied in future studies by 
health institutions in order to unify criteria 
and improve existing protocols, with the 
ultimate goal of offering top quality medi-
cal care. 
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